Yinghui Ye

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Treatment and prognosis of patients with hormone receptor-low positive (1%-10%) breast cancer: a retrospective propensity score-matched analysis.

Treatment and prognosis of patients with hormone receptor-low positive (1%-10%) breast cancer: a retrospective propensity score-matched analysis.

Journal: Breast cancer (Tokyo, Japan)

Published: April 04, 2025

Single-Cell Transcriptomic Profiling Reveals KRAS/TP53-Driven Neutrophil Reprogramming in Luad: A Multi-Gene Prognostic Model and Therapeutic Targeting of RHOV.

Single-Cell Transcriptomic Profiling Reveals KRAS/TP53-Driven Neutrophil Reprogramming in Luad: A Multi-Gene Prognostic Model and Therapeutic Targeting of RHOV.

Journal: Oncology research

Published: December 21, 2024

Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma.

Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma.

Journal: PloS one

Published: October 05, 2024

Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China.

Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China.

Journal: Hematology (Amsterdam, Netherlands)

Published: May 31, 2024

A New Hemoglobin Variant: Hb Tangshan [HBA1: c.239C > T, CD79(GCG > GTG)(Ala > Val)] Detected by MALDI-TOF MS.

A New Hemoglobin Variant: Hb Tangshan [HBA1: c.239C > T, CD79(GCG > GTG)(Ala > Val)] Detected by MALDI-TOF MS.

Journal: Hemoglobin

Published: November 01, 2023

Identification of Hb Lepore, Hb anti-Lepore, and α-globin gene triplications by long-read single-molecule real-time sequencing.

Identification of Hb Lepore, Hb anti-Lepore, and α-globin gene triplications by long-read single-molecule real-time sequencing.

Journal: American journal of clinical pathology

Published: July 31, 2023

Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity.

Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity.

Journal: Journal of cancer research and clinical oncology

Published: May 29, 2023

Mutational spectrum of HBD gene in the Chinese population: Description of 36 mutations including 11 novel variants.

Mutational spectrum of HBD gene in the Chinese population: Description of 36 mutations including 11 novel variants.

Journal: International journal of laboratory hematology

Published: April 26, 2023

Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma.

Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma.

Journal: Frontiers in endocrinology

Published: March 03, 2023

New insights into COL26A1 in thyroid carcinoma: prognostic prediction, functional characterization, immunological drug target and ceRNA network.

New insights into COL26A1 in thyroid carcinoma: prognostic prediction, functional characterization, immunological drug target and ceRNA network.

Journal: Translational cancer research

Published: February 01, 2023

A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer.

A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer.

Journal: Frontiers in immunology

Published: January 09, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026